Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: Post-approval Japanese population experience

International Journal of Clinical Oncology

Volumn 12, Issue 3, 2007, Pages 218-223

  Shimizu, Toshio ^a   Satoh, Taroh ^b   Tamura, Kenji ^a   Ozaki, Tomohiro ^a   Okamoto, Isamu ^b   Fukuoka, Masahiro ^b   Nakagawa, Kazuhiko ^b  

^a KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; FOLFOX; Japanese population; Oxaliplatin

Indexed keywords

ANTIHISTAMINIC AGENT; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; GRANISETRON; IRINOTECAN; OXALIPLATIN; STEROID;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CHEMOTHERAPY INDUCED EMESIS; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG APPROVAL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSESTHESIA; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HAND FOOT SYNDROME; HUMAN; INCIDENCE; JAPANESE; LETHARGY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PARESTHESIA; PIGMENT DISORDER; PRIORITY JOURNAL; RADIOLOGY; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; SIDE EFFECT; THERAPY DELAY; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; JAPAN; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250650940     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0658-x     Document Type: Article

References (14)

1. MA Poon MJ O'Connell CG Moertel 1989 Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma J Clin Oncol 7 1407 1418
2. F Levi R Zidani JL Misset 1997 Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer: International Organization for Cancer Chronotherapy Lancet 350 681 686
3. S Giacchetti B Perpoint R Zidani 2000 Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 136 147
4. JY Douillard D Cunningham AD Roth 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041 1047
5. D Machover E Diaz-Rubio A de Gramont 1996 Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines Ann Oncol 7 95 98
6. F Levi B Perpoint C Garufi 1993 Oxaliplatin activity against metastatic colorectal cancer: a phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate Eur J Cancer 29A 1280 1284
7. E Diaz-Rubio J Sastre A Zaniboni 1998 Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study Ann Oncol 9 105 108
8. Y Becouarn M Ychou M Ducreux 1998 A phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients J Clin Oncol 8 2739 2744
9. A de Gramont J Vignoud C Tournigand 1997 Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer Eur J Cancer 33 214 219
10. E Raymond C Buquet-Fagot S Djelloul 1997 Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast, and ovarian cancers Anticancer Drugs 8 876 885
11. RM Goldberg DJ Sargent SR Alberts 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30
12. A de Gramont A Figer A Bonetti 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947
13. C Tournigand T Andre A de Gramont 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237
14. MS Braun F Adab MT Seymour 2003 Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer Br J Cancer 89 1155 1158